Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre‐diabetes and diabetes. The KORA Myocardial Infarction Registry
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The lowest glycemic threshold for and the risk factors associated with neuropathic pain have not been established. The aim of this study was to determine the prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), normal glucose tolerance (NGT). Subjects aged 25–74 years with diabetes (n=214) and controls matched for age and sex (n=212) from the population‐based KORA (Cooperative Health Research in the Region of Augsburg) Myocardial Infarction Registry were assessed for neuropathic pain by the Michigan Neuropathy Screening Instrument using its pain‐relevant questions and an examination score cutpoint >2. An oral glucose tolerance test was performed in the controls. Among the controls, 61 (28.8%) had IGT (either isolated or combined with IFG), 70 (33.0%) had isolated IFG, and 81 had NGT. The prevalence of neuropathic pain was 21.0% in the diabetic subjects, 14.8% in those with IGT, 5.7% in those with IFG, and 3.7% in those with NGT (overall p<0.001). In the entire population studied (n=426), age, waist circumference, peripheral arterial disease (PAD), and diabetes were independent factors significantly associated with neuropathic pain, while in the diabetic group it was waist circumference, physical activity, and PAD (all p<0.05). In conclusion, the prevalence of neuropathic pain is relatively high among survivors of myocardial infarction with diabetes and IGT compared to those with isolated IFG and NGT. Associated cardiovascular risk factors including abdominal obesity and low physical activity may constitute targets to prevent neuropathic pain in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323 · cited 2×
“We hypothesized that if vascular disease is an important factor in the development of polyneuropathy as recently suggested (Cameron et al., 2001; Tesfaye et al., 2005), the prevalence of the latter should be increased in patients with macroangiopathy evidenced by a MI.”
BackgroundHoffman-Snyder, C., Smith, B. E., Ross, M. A., Hernandez, J., & Bosch, E. P. (2006) · Archives of Neurology · doi:10.1001/archneur.63.8.noc50336 · Cited by 100 · cited 4×
“In the only controlled study hitherto available 32% of patients with CIAP and 14% of the controls had IGT or fasting hyperglycemia but, after adjusting for age and sex, the difference was not significant, even in the painful neuropathy subgroup (Hughes et al., 2004).”
BackgroundInfluential
Cited by
Abbott, C. A., Malik, R. A., van Ross, E. R. E., Kulkarni, J., & Boulton, A. J. M. (2011) · Diabetes Care · doi:10.2337/dc11-1108 · Cited by 868
Vinik, A. I., Nevoret, M.-L., Casellini, C., & Parson, H. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.06.001 · Cited by 366
Mechanisms and Management of Diabetic Painful Distal Symmetrical Polyneuropathy
Tesfaye, S., Boulton, A. J. M., & Dickenson, A. H. (2013) · Diabetes Care · doi:10.2337/dc12-1964 · Cited by 348
Azmi, S., Ferdousi, M., Petropoulos, I. N., Ponirakis, G., Alam, U., Fadavi, H., Asghar, O., Marshall, A., Atkinson, A. J., Jones, W., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2733 · Cited by 148
Diabetic Sensory and Motor Neuropathy
Vinik, A. I. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1503948 · Cited by 113
Ziegler, D., Strom, A., Lobmann, R., Reiners, K., Rett, K., & Schnell, O. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.09.008 · Cited by 48
Self-citationThe Epidemiology of Diabetic Neuropathy
Hansen, C. S., Määttä, L. L., Andersen, S. T., & Charles, M. H. (2023) · Contemporary Diabetes · doi:10.1007/978-3-031-15613-7_2 · Cited by 17
Metadata
- Authors
- Ziegler, D., Rathmann, W., Meisinger, C., Dickhaus, T., Mielck, A., & For the KORA Study Group
- Venue
- European Journal of Pain
- Publisher
- Wiley
- Published
- 2009-07
- Volume
- 13
- Issue
- 6
- Pages
- 582-587
- ISSN
- 1090-3801 (ISSN-L)
- 1532-2149
- OpenAlex
- W2139363484
- Cited by
- 87
- References
- 4
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.